PREDIGEN

Welcome to the Brand page for “PREDIGEN”, which is offered here for Diagnostic testing materials, diagnostic preparations for medical testing purposes, diagnostic preparations, and diagnostic reagents all for the detection and diagnosis of covid-19; diagnostic testing materials for the detection and diagnosis of viral, bacterial and fungal infections, sepsis, cardiovascular disease, radiation exposure, autoimmune and inflammatory disease and cancer;medical testing for diagnostic or treatment purposes; medical testing for diagnostic or treatment purposes for diagnosis of covid-19; medical testing for diagnostic or treatment purposes for diagnosis of viral, bacterial and fungal infections, sepsis, cardiovascular disease, radiation exposure, autoimmune and inflammatory disease and cancer;biotechnology research; research and development of vaccines and medicines for the treatment of covid-19; consulting services in the fields of biotechnology, pharmaceutical research and development, genetic science laboratory testing, diagnostics, and pharmacogenetics research; development of new technology for others in the field of biotechnology;.

Its status is currently believed to be active. Its class is unavailable. “PREDIGEN” is believed to be currently owned by “Biomeme, Inc.”